首页> 外文OA文献 >Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer

【2h】

Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer

机译：小细胞肺癌转化和T790M突变：肺癌激素抑制剂的抗互补作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kenichi Suda; Isao Murakami; Kazuko Sakai; Hiroshi Mizuuchi; Shigeki Shimizu; Katsuaki Sato; Kenji Tomizawa; Shuta Tomida; Yasushi Yatabe; Kazuto Nishio; Tetsuya Mitsudomi;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 第一代酪氨酸激酶抑制剂治疗中发生进展的非小细胞肺癌血浆表皮生长因子受体(EGFR) T790M突变提示了失败部位并预测了临床预后:一项前瞻性观察研究 [J] . Shirong Zhang, Lucheng Zhu, Bing Xia, 癌症（英文版） . 2018,第009期
2. Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer [J] . Kenichi Suda, Isao Murakami, Kazuko Sakai, Scientific reports. . 2015,第1期

机译：小细胞肺癌转化和T790M突变：在肺癌获得性抗激酶抑制剂中的互补作用
3. Concomitant T790M mutation and small-cell lung cancer transformation after acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor [J] . Maria Cristina Lucanto, Kohei Fujita, Mariangela Lombardo, Respirology Case Reports . 2016,第1期

机译：对表皮生长因子受体酪氨酸激酶抑制剂获得耐药后伴随的T790M突变和小细胞肺癌转化
4. Concomitant T790M mutation and small-cell lung cancer transformation after acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor [J] . Maria Cristina Lucanto, Kohei Fujita, Mariangela Lombardo, Respirology Case Reports . 2016,第1期

机译：对表皮生长因子受体酪氨酸激酶抑制剂获得耐药后伴随的T790M突变和小细胞肺癌转化
5. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
6. Pharmacology Profiles of ALK and FLT3 Kinase Inhibitors against Non-Small-Cell Lung Cancer Cells and Acute Myeloid Leukemia Cells with Cancer Driver Mutations [D] . 森政道 2019

机译：ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
7. Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer [O] . Kenichi Suda, Isao Murakami, Kazuko Sakai, -1

机译：小细胞肺癌转化和T790M突变：在肺癌的激酶抑制剂获得性耐药中的互补作用
8. Concomitant T790M mutation and small-cell lung cancer transformation after acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor [O] . Fujita, Kohei, Kim, Young Hak, Yoshizawa, Akihiko, 2017

机译：对表皮生长因子受体酪氨酸激酶抑制剂获得耐药后伴随的T790M突变和小细胞肺癌转化

Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer

著录项

引文网络

相似文献

相关主题

期刊订阅